Deucravacitinib HCl - CAS 1609392-28-0

Deucravacitinib HCl is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. MS-986165 potently binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM), and is highly selective against a panel of 265 kinases and pseudokinases. The compound potently inhibited IL-23-, IL-12-, and Type I interferon-driven cellular signaling and transcriptional responses (IC50 range 2-14 nM) .

JAK, Interleukin, IFNAR

JAK/STAT signaling, Stem Cells, Immunology/Inflammation, Angiogenesis, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic

1609364

C20H20D3ClN8O3

461.93

Cl.[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC

-20°C

Ice Packs

Isotope products